Banque Transatlantique Sa Spero Therapeutics, Inc. Call Options Transaction History
Banque Transatlantique Sa
- $5.69 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SPRO
# of Institutions
43Shares Held
18.2MCall Options Held
9.3KPut Options Held
100-
Anson Funds Management LP Dallas, TX7.64MShares$5.19 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$1.2 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$920,24614.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny971KShares$660,2160.0% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$605,1850.06% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $23.8M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...